FDA Adverse Event Malfunction Summary report: N

VASOVIEW HEMOPRO EVH SYSTEM

MDR report key: 2080940 · Received April 13, 2011

Report

Report Number
2242352-2011-00273
Event Type
Malfunction
Date Received
April 13, 2011
Date of Event
March 11, 2011
Report Date
March 15, 2011
Manufacturer
MAQUET CARDIOVASCULAR, LLC.
Product Code
GEI
PMA / PMN Number
K052274
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION: VISUAL INSPECTION REVEALED THAT THE TOOL WAS RECEIVED INSIDE THE CANNULA. THE CANNULA BLUNT TIP AND C-RING WERE MELTED. THE TISSUE WELDER COLD JAW SILICONE BOOT WAS COMPLETELY MELTED AND DETACHED. THE COLD JAW SILICONE BOOT WAS ALMOST COMPLETELY MELTED AND DETACHED. THERE WAS SOME EVIDENCE OF BLOOD. A PRE-CAUTERY TEST WAS PERFORMED ON THE DEVICE WITH A REFERENCE POWER SUPPLY AND EXTENSION CABLE. THE DEVICE PASSED THE PRE-CAUTERY TEST, IT PRODUCED STEAM AND HEAT DURING SEVERAL ACTIVATIONS AND SHUT OFF WHEN THE TOGGLE WAS RELEASED. BASED UPON THE OBSERVATION OF THE JAWS AND CANNULA TIP MELTED, THE REPORTED FAILURE "DEVICE REMAINS ACTIVATED" WAS CONFIRMED. A LOT HISTORY RECORD REVIEW WAS COMPLETED FOR THE PRODUCT. THERE WAS NO NONCONFORMANCE WHICH COULD HAVE CONTRIBUTED TO THIS FAILURE MODE. INTERNAL FILE NUMBER - (B)(4).

Description of Event or Problem · 1

THE HOSP REPORTED THAT DURING AN ENDOSCOPIC VESSEL HARVESTING PROCEDURE, TWO VASOVIEW HEMOPRO UNITS HAD ELECTRICAL FAILURES. THE FIRST UNIT OVERHEATED, MELTED THE JAWS AND TIP AND REMAINED ACTIVATED. THE SECOND, REPLACEMENT UNIT WOULD NOT CAUTERIZE, "CAUSING MORE BLEEDING." A REPLACEMENT UNIT WAS USED TO COMPLETE THE PROCEDURE. THE HOSPITAL DID NOT REPORT ANY PT EFFECTS. THE PRODUCT WAS RETURNED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VASOVIEW HEMOPRO EVH SYSTEM ENDOSCOPIC VESSEL HARVESTING SYSTEM GEI MAQUET CARDIOVASCULAR, LLC. VH-3000 25029366

Patients

Seq Age Sex Outcome Treatment
1 NA